Renal Outcomes Among Post Liver Transplantation Patients
Short Term Renal Outcomes Among Post Liver Transplantation Patients at Assiut University
1 other identifier
observational
50
0 countries
N/A
Brief Summary
To evaluate Renal outcomes among patients, post liver transplantation at Assiut university.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Dec 2023
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 2, 2023
CompletedFirst Posted
Study publicly available on registry
November 8, 2023
CompletedStudy Start
First participant enrolled
December 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2025
CompletedNovember 8, 2023
November 1, 2023
1 year
November 2, 2023
November 7, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
calculation the incidence of AKI in Liver transplantation patients
Determination of the most common risk factor for AKI in liver transplantation patients.
Baseline
Secondary Outcomes (1)
mortality rate
Baseline
Interventions
BUN, eGFR , CBC , Electrolytes , Liver function tests
Eligibility Criteria
retrospective cohort study will be done to patients post liver transplantation at El Raghy university hospital
You may qualify if:
- Data of all Patients underwent liver transplants with their reports available at El Raghy university hospital
You may not qualify if:
- Inadequate data
- Patients on dialysis more than 8 weeks pre liver transplant.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (7)
Feffer SE, Parray HR, Westring DW. Seizure after infusion of aminocaproic acid. JAMA. 1978 Nov 24;240(22):2468. No abstract available.
PMID: 101682BACKGROUNDRautela GS, Snee RD, Miller WK. Response-surface co-optimization of reaction conditions in clinical chemical methods. Clin Chem. 1979 Nov;25(11):1954-64.
PMID: 498506BACKGROUNDRamakrishnan R, Mittal S, Ambatkar S, Kader MA. Retinal nerve fibre layer thickness measurements in normal Indian population by optical coherence tomography. Indian J Ophthalmol. 2006 Mar;54(1):11-5. doi: 10.4103/0301-4738.21608.
PMID: 16531664BACKGROUNDBraun OH, Kreipe U. [Rare forms of chronic osteomyelitis in children (author's transl)]. Klin Padiatr. 1979 Sep;191(5):511-21. German.
PMID: 574584BACKGROUNDPannuti F. Surgical adjuvant hormone therapy in breast cancer. Arch Geschwulstforsch. 1978;48(7):680-2. No abstract available.
PMID: 736749BACKGROUNDPozenel H. [The influence of mexiletin on ventricular arrhythmias during ergometric exercise (author's transl)]. Wien Klin Wochenschr. 1977 Dec 9;89(23):783-8. German.
PMID: 595602BACKGROUNDBlom E. A decapitated sperm defect in two sterile Hereford bulls. Nord Vet Med. 1977 Mar;29(3):119-23.
PMID: 870880BACKGROUND
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Bahaa Osman Taha, Master
Bahaa_osman99@aun.edu.eg
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 3 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- doctor
Study Record Dates
First Submitted
November 2, 2023
First Posted
November 8, 2023
Study Start
December 1, 2023
Primary Completion
December 1, 2024
Study Completion
January 1, 2025
Last Updated
November 8, 2023
Record last verified: 2023-11